XML 36 R17.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS | 12 Months Ended
--- | ---
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS | GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS The changes in the carrying amount of goodwill by reportable segment and Corporate and Other for the fiscal years ended June 30, 2024 and 2023 were as follows:
| Goodwill
| Health and Wellness |  | Household |  | Lifestyle |  | International |  | Corporate and Other (1) |  | Total
Balance as of June 30, 2022 | $ | 323 |  |  | $ | 85 |  |  | $ | 244 |  |  | $ | 600 |  |  | $ | 306 |  |  | $ | 1,558 |
Goodwill impairment | — |  |  | — |  |  | — |  |  | — |  |  | (306) |  |  | (306) |
Balance as of June 30, 2023 | $ | 323 |  |  | $ | 85 |  |  | $ | 244 |  |  | $ | 600 |  |  | $ | — |  |  | $ | 1,252 |
Divestiture (2) | — |  |  | — |  |  | — |  |  | (16) |  |  | — |  |  | (16) |
Effect of foreign currency translation | — |  |  | — |  |  | — |  |  | (8) |  |  | — |  |  | (8) |
Balance as of June 30, 2024 | $ | 323 |  |  | $ | 85 |  |  | $ | 244 |  |  | $ | 576 |  |  | $ | — |  |  | $ | 1,228 |
(1)Reflects goodwill related to the Better Health VMS reporting unit, which was previously included within the Health and Wellness reportable segment prior to the segment changes effective in the fourth quarter of fiscal year 2023. (2)Reflects goodwill related to the divestiture of the Argentina business. See Note 2 for additional information. The changes in the carrying amount of trademarks and other intangible assets for the fiscal years ended June 30, 2024 and 2023 were as follows:
| As of June 30, 2024 |  | As of June 30, 2023
| Gross carrying amount |  | Accumulated amortization / Impairments |  | Net carrying amount |  | Gross carrying amount |  | Accumulated amortization / Impairments |  | Net carrying amount
Trademarks with indefinite lives (1) | $ | 493 |  |  | $ | — |  |  | $ | 493 |  |  | $ | 494 |  |  | $ | — |  |  | $ | 494 |
Trademarks with finite lives (1) | 83 |  |  | 38 |  |  | 45 |  |  | 89 |  |  | 40 |  |  | 49 |
Other intangible assets with finite lives | 578 |  |  | 435 |  |  | 143 |  |  | 579 |  |  | 410 |  |  | 169 |
Total | $ | 1,154 |  |  | $ | 473 |  |  | $ | 681 |  |  | $ | 1,162 |  |  | $ | 450 |  |  | $ | 712 |
(1)As of June 30, 2023 reflects changes to the useful lives of certain Better Health VMS and International indefinite-lived trademarks to finite-lived effective April 1, 2023. Amortization expense relating to the Company’s intangible assets was $29, $30 and $31 for the years ended June 30, 2024, 2023 and 2022, respectively. Estimated amortization expense for these intangible assets is $28, $28, $29, $28 and $11 for fiscal years 2025, 2026, 2027, 2028 and 2029, respectively. Fiscal Year 2023 Impairments During the third quarter of fiscal year 2023, management made a decision to narrow the focus on core brands and streamline investment levels in the Better Health VMS business. As a result, revisions were made to the internal financial projections and operational plans of the Better Health VMS business reflecting the Company’s current estimates regarding the future financial performance of these operations and macroeconomic factors. The revised estimated future cash flows reflected lower sales growth expectations and lower investment levels. These revisions were considered a triggering event requiring interim impairment assessments to be performed as part of the preparation of the quarterly financial statements on the global indefinite-lived trademarks, other long-term assets and the Better Health VMS reporting unit. Based on the outcome of these assessments, the following pre-tax, noncash impairment charges were recorded during fiscal year 2023:
| Impairment Charges
| Better Health VMS reporting unit | International reporting unit | Total
Goodwill | $ | 306 |  | $ | — |  | $ | 306 |
Trademarks, net | 127 |  | 12 |  | 139 |
Total | $ | 433 |  | $ | 12 |  | $ | 445 |
In connection with recognizing these impairment charges, the Company recognized tax benefits related to the impairments of $83 due to the partial tax deductibility of these charges. To determine the estimated fair values of the global indefinite-lived trademarks related to the Better Health VMS business, the Company used the DCF method under the relief from royalty income approach. This approach requires significant judgments in determining the royalty rates and the assets’ estimated cash flows as well as the appropriate discount rates applied to those cash flows to determine fair value. A s a result of the interim impairment test, the Company concluded that the carrying value of the global indefinite-lived trademarks exceeded their estimated fair value, and recorded impairment charges of $139. In addition, the useful lives of the impaired trademarks, with a remaining net carrying value of $28 as of March 31, 2023, were changed from indefinite to finite beginning on April 1, 2023, which reflects the remaining expected useful lives of the trademarks based on the most recent financial and operational plans. The weighted-average estimated useful life of these trademarks is 20 years. After adjusting the carrying values of the global indefinite-lived trademarks and concluding that the carrying amounts of the other long-lived assets were recoverable, the Co mpany completed a quantitative impairment test for goodwill and recorded a goodwill impairment charge of $306 in the Better Health VMS reporting unit. To determine the fair value of the Better Health VMS reporting unit, the Company used a DCF method under the income approach. In accordance with this approach, the Company estimated the future cash flows of the Better Health VMS reporting unit and discounted these cash flows at a rate of return that reflects its relative risk. The other key estimates and factors used in the DCF method include, but are not limited to, net sales and expense growth rates and a terminal growth rate. The decrease in projected cash flows due to the revisions adversely impacted key assumptions used in determining the fair value of the Better Health VMS reporting unit and assets contained therein, primarily projected net sales. There is no remaining goodwill associated with the impaired reporting unit. No other significant impairments were identified as a result of the Company’s impairment reviews during fiscal years 2024, 2023 and 2022.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration